13F

Stock

Biomarin Pharmaceutical Inc

BMRN · held by 8 managers

Reported value

$28.8M

Holders

8

+1 new · −0 exited

Holders’ est. mark

$8.93M

Price effect on 5 books still in the name

Largest holder

$21.8M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC502.9K$21.8M$9.31MAdded$1.04M
DANSKE BANK A/S80.1K$5.26M−$329.5KAdded$184.9K
Leonteq Securities AG12K$789.1K−$40.1KAdded$171.3K
Swiss Life Asset Management Ltd11.7K$766.2KNew
Burton Enright Welch3.68K$242.1K−$16.8KCut−$16.9K
Aventura Private Wealth, LLC49$3.22KHeld
Prestige Wealth Management Group LLC34$2.23K−$155Cut−$1.91K

Positions as of Q4 2024. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.